首页> 外文期刊>Post?py Higieny i Medycyny Do?wiadczalnej >The role of stromal mast cells in the modification of CD4+CD25+Foxp3 regulatory T cells, Th17 lymphocytes and cytotoxic lymphocytes Tc1 in the development and progression of tumor
【24h】

The role of stromal mast cells in the modification of CD4+CD25+Foxp3 regulatory T cells, Th17 lymphocytes and cytotoxic lymphocytes Tc1 in the development and progression of tumor

机译:基质肥大细胞在发育中CD4 + CD25 + Foxp 3 调节性T细胞,Th17淋巴细胞和细胞毒性淋巴细胞Tc1修饰中的作用与肿瘤的进展

获取原文
           

摘要

Despite the lack of direct evidence that immune surveillance cells protect against tumor development, indirect clinical observations and experimental studies indicate activity in the immune response against cancer cells of various origin. Little is known about the effects of the stromal tumor mast cell (MC) in the activity of immune cells, i.e. CD4+CD25+Foxp3+ regulatory T cells, Th17 lymphocytes, cytotoxic lymphocytes Tc1 and their mutual modulatory function and regulation of the antitumor immune response. Factors synthesized by stromal tumor mast cells including histamine, COX-2, CXCL8 (IL-8), VEGF, IL-6, TNF, iNOS, MMP-8, and MMP-9 may, on the one hand, directly affect the activity of T lymphocyte subpopulations, i.e. iTreg, Tc1, and Th17, and thus regulate immunological processes occurring in the vicinity of the tumor. On the other hand, through effects on angiogenesis, apoptosis, the cell cycle, secretion of cytokines and the expression of adhesion molecules, they may indirectly determine the progression of the neoplasm. Understanding the regulatory mechanisms occurring in the system: tumor stroma mast cell → immune cells infiltrating the tumor (iTreg, Tc1, Th17 lymphocytes) → expression of factors involved in angiogenesis, apoptosis, the cell cycle, and secretion of cytokines and adhesion molecules creates the future possibility of influencing the activation and regulation of selected proneoplastic and antineoplastic factors appearing in the neoplasm environment. Research on these mechanisms may be the beginning of a new approach to the fight against cancer growth and provide an opportunity to introduce new methods of treatment. The aim of this study was to present the current knowledge on the role of stromal tumor CD117+ mast cells and factors secreted by these cells in the activation of T lymphocyte subpopulations, i.e. CD4+CD25+Foxp3+ regulatory T cells, Th17 lymphocytes, and cytotoxic lymphocytes Tc1, as well as to present their impact on the degree of tumor invasiveness by regulating the synthesis of factors secreted by the lymphocyte subpopulations studied, e.g. IL-10 and TGF-β (iTreg), IL-17A and IL-6 (Th17), IFN-γ and IL-2 (Tc1).
机译:尽管缺乏直接的证据表明免疫监视细胞可以防止肿瘤的发展,但是间接的临床观察和实验研究表明,免疫监视细胞可以抵抗多种来源的癌细胞。关于基质肿瘤肥大细胞(MC)对免疫细胞活性的影响知之甚少,即CD4 + CD25 + Foxp3 + 调节性T细胞,Th17淋巴细胞,细胞毒性淋巴细胞Tc1及其相互调节功能和抗肿瘤免疫反应的调节。一方面,由间质肿瘤肥大细胞合成的因子包括组胺,COX-2,CXCL8(IL-8),VEGF,IL-6,TNF,iNOS,MMP-8和MMP-9可能直接影响其活性T淋巴细胞亚群(即iTreg,Tc1和Th17)的表达,从而调节发生在肿瘤附近的免疫过程。另一方面,通过对血管生成,细胞凋亡,细胞周期,细胞因子分泌和粘附分子表达的影响,它们可以间接决定肿瘤的进展。了解系统中发生的调节机制:肿瘤基质肥大细胞→浸润肿瘤的免疫细胞(iTreg,Tc1,Th17淋巴细胞)→涉及血管生成,凋亡,细胞周期以及细胞因子和粘附分子分泌的因子的表达影响在肿瘤环境中出现的某些促肿瘤和抗肿瘤因子的激活和调节的未来可能性。对这些机制的研究可能是对抗癌症生长的新方法的开端,并为引入新的治疗方法提供了机会。这项研究的目的是提供有关间质性肿瘤CD117 + 肥大细胞以及这些细胞分泌的因子在T淋巴细胞亚群激活中的作用的最新知识,即CD4 + CD25 + Foxp3 + 调节性T细胞,Th17淋巴细胞和细胞毒性淋巴细胞Tc1,以及通过调节SUP> CD25的合成对肿瘤侵袭程度的影响研究的淋巴细胞亚群分泌的因子,例如IL-10和TGF-β(iTreg),IL-17A和IL-6(Th17),IFN-γ和IL-2(Tc1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号